Patents Assigned to InnaMed, Inc.
  • Publication number: 20230042710
    Abstract: Described herein are nucleic acid-based electrochemical proximity assays (ECPAs) for sample quantification. The invention may also include a biosensor with a sensing mechanism that uses a pair of aptamers or antibodies that bind the target of interest. More specifically, the invention relates to an electrochemical-based read out of a sensing mechanism that uses a nucleic acid-based proximity assay in conjunction with a pair of aptamers or antibodies for sample quantification. The biosensor or a set of biosensors can be used either as a standalone measurement system for a single analyte target or as a component of a multiplexed cartridge for multiple analytes.
    Type: Application
    Filed: December 31, 2020
    Publication date: February 9, 2023
    Applicants: INNAMED, INC., AUBURN UNIVERSITY
    Inventors: Katarena I. FORD, Niamat E. KHUDA, Asanka GURUKANDURE GEDARA, Christopher J. EASLEY, Subramaniam SOMASUNDARAM, Anup SINGH, Eshwar INAPURI
  • Patent number: 11505799
    Abstract: Provided herein are aptamers for binding lipoproteins, systems for binding lipoproteins, and methods of detecting lipoproteins in a sample. The aptamers are useful for detecting the levels of lipoproteins in a biological sample and selectively detecting LDL particles in the presence of HDL particles. The aptamers can also be used as therapeutic agents against various diseases.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: November 22, 2022
    Assignee: InnaMed, Inc.
    Inventors: Eshwar Inapuri, Anup Singh, Gregory Allen Penner